rs971818

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1777+20064G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.704 in 152,028 control chromosomes in the GnomAD database, including 37,939 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 37939 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.39

Publications

5 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1777+20064G>A intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.1777+20064G>A intron_variant Intron 11 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1777+20064G>A intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000636870.1 linkn.1639+20064G>A intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1260+20064G>A intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1680+20064G>A intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.704
AC:
106919
AN:
151910
Hom.:
37916
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.775
Gnomad AMI
AF:
0.629
Gnomad AMR
AF:
0.642
Gnomad ASJ
AF:
0.715
Gnomad EAS
AF:
0.574
Gnomad SAS
AF:
0.556
Gnomad FIN
AF:
0.709
Gnomad MID
AF:
0.718
Gnomad NFE
AF:
0.694
Gnomad OTH
AF:
0.704
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.704
AC:
106986
AN:
152028
Hom.:
37939
Cov.:
31
AF XY:
0.700
AC XY:
52030
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.775
AC:
32159
AN:
41470
American (AMR)
AF:
0.641
AC:
9800
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.715
AC:
2482
AN:
3472
East Asian (EAS)
AF:
0.573
AC:
2951
AN:
5154
South Asian (SAS)
AF:
0.556
AC:
2675
AN:
4814
European-Finnish (FIN)
AF:
0.709
AC:
7480
AN:
10544
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.694
AC:
47176
AN:
67984
Other (OTH)
AF:
0.704
AC:
1485
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1596
3192
4788
6384
7980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.696
Hom.:
158595
Bravo
AF:
0.703
Asia WGS
AF:
0.615
AC:
2138
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
8.5
DANN
Benign
0.71
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs971818; hg19: chr7-147203197; API